module.exports = [
    {
        title: "Moderator",
        name: "Lord Ajay K. Kakkar, MD, PhD",
        affiliation: `
        Professor of Surgery
        <br/>
        University College London
        <br/>
        London, United Kingdom
        `,
        disclosure: `
        Disclosure: Lord Ajay K. Kakkar, MD, PhD,  has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Daiichi Sankyo, Inc.; Janssen Pharmaceuticals; Sanofi; Verseon
        
        <br/>Received grants for clinical research from: Bayer HealthCare
        
        <br/><br/>Dr Kakkar does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
        
        <br/><br/>Dr Kakkar does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
        `
    },
    {
        title: "Panelists",
        name: "Alok A. Khorana, MD",
        affiliation: `
        Professor of Medicine 
        <br/>
        Cleveland Clinic Lerner College of Medicine
        <br/>
        Case Western Reserve University Sondra and Stephen Hardis Chair in Oncology Research
        <br/>
        Vice Chair (Clinical Services)
        <br/>
        Director
        <br/>
        GI Malignancies Program
        <br/>
        Taussig Cancer Institute
        <br/>
        Cleveland Clinic
        <br/>
        Cleveland, Ohio, United States
        `,
        disclosure: `
        Disclosure: Alok A. Khorana, MD, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: AngioDynamics, Inc; Bayer HealthCare; Halozyme Therapeutics; Janssen Pharmaceuticals; Pfizer Inc.
        
        <br/>Received grants for clinical research from: Amgen
        
        <br/><br/>Dr Khorana does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
        
        <br/><br/>Dr Khorana does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
        `
    },
    {
        title: "Panelists",
        name: "Jeffrey I. Weitz, MD, FRCP",
        affiliation: `
        Professor of Medicine and Biochemistry
        <br/>
        McMaster University
        <br/>
        Hamilton, Ontario, Canada
        `,
        disclosure: `
        Disclosure: Jeffrey I. Weitz, MD, FRCP, has disclosed the following relevant financial relationships: 

        <br/>Served as an advisor or consultant for: Bayer HealthCare; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Daiichi Sankyo, Inc.; Ionis; Janssen Pharmaceuticals; Merck --AMPERSAND--amp; Co., Inc.; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Portola Pharmaceuticals, Inc.
        
        <br/><br/>Dr Weitz does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.
        
        <br/><br/>Dr Weitz does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.
        `
    }
];